Ranitidine bismuth citrate or omeprazole-based triple therapy for H-pylori eradication in H-pylori-infected nonulcer dyspepsia

被引：0
作者：
Chuang, CH
Sheu, BS
Yang, HB
Wu, JJ
Lin, XZ
机构：
[1] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Dept Pathol, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Dept Med Technol, Tainan 70101, Taiwan
来源：
GUT | 2001年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1543
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [41] A quintuple therapy for H-Pylori eradication
    Zullo, Angelo
    Lorenzetti, Roberto
    Hassan, Cesare
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11) : 2601 - 2601
  • [42] Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication
    Spadaccini, A
    De Fanis, C
    Sciampa, G
    Russo, L
    Silla, M
    Pantaleone, U
    Di Virgilio, M
    Pizzicanella, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) : 997 - 1001
  • [43] A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia
    Laurent, J
    Mégraud, F
    Fléjou, JF
    Caekaert, A
    Barthélemy, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (11) : 1787 - 1793
  • [44] Prospective randomized comparisons of ranitidine bismuth citrate (RBC) versus colloidal bismuth subcitrate (Denol)-based triple therapy for the treatment of H-pylori infection.
    Kung, NNS
    Sung, JY
    Yuen, WF
    Li, TH
    Ng, PW
    Lai, WM
    Leung, MF
    GASTROENTEROLOGY, 1998, 114 (04) : A190 - A190
  • [45] Another no-benefit finding on H-pylori treatment in nonulcer dyspepsia
    不详
    GASTROENTEROLOGY, 1999, 117 (06) : 1268 - 1268
  • [46] Helicobacter pylori positive duodenal ulcer treated with omeprazole vs ranitidine bismuth citrate triple therapy
    Catalano, F
    Catanzaro, R
    Bentivegna, C
    Branciforte, G
    Brogna, A
    Liberti, A
    Cipolla, R
    Blasi, A
    GUT, 1997, 41 : A213 - A213
  • [47] Ranitidine bismuth citrate (RBC)-based triple therapies for recurring Helicobacter pylori (Hp) eradication
    Yakovenko, A
    Grigoriev, P
    Yakovenko, E
    Abazova, F
    Poliakov, A
    Agafonova, N
    Pryanishnikova, A
    Chtcherbina, E
    Gulyaev, P
    Gorodinskaya, V
    Avanyan, N
    GUT, 1999, 45 : A117 - A118
  • [48] Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication
    Uygun, A.
    Kadayifci, A.
    Yesilova, Z.
    Ates, Y.
    Safali, M.
    Ilgan, S.
    Bagci, S.
    Dagalp, K.
    HELICOBACTER, 2007, 12 (04) : 429 - 430
  • [49] One-week therapy with omeprazole (PPI) or ranitidine bismuth citrate (RBC) and two antibiotics for eradication of H-pylori in duodenal ulcer (DU): Interim report of a multicentre study
    Spinzi, G
    Boni, F
    Ballardini, G
    Prada, A
    Venturelli, R
    Minoli, G
    GASTROENTEROLOGY, 1999, 116 (04) : A317 - A317
  • [50] The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection
    Van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    GUT, 1998, 43 : A86 - A86
12345